ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,460.48
-0.41%
US Tech 100
19,181.60
-0.43%
다우존스 지수
39,118.86
-0.12%
Bitcoin
60,729.16
0.69%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Mirati Therapeutics Inc (MRTX)

  7. Mirati Therapeutics Inc (MRTX) 뉴스

MRTX

Mirati Therapeutics (MRTX)

Mirati Therapeutics Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:MRTX
일자시간출처헤드라인심볼기업
2024/02/1504:51Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MRTXMirati Therapeutics Inc
2024/02/1423:13Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MRTXMirati Therapeutics Inc
2024/02/0306:05Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:MRTXMirati Therapeutics Inc
2024/01/2514:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MRTXMirati Therapeutics Inc
2024/01/2514:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MRTXMirati Therapeutics Inc
2024/01/2514:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MRTXMirati Therapeutics Inc
2024/01/2410:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRTXMirati Therapeutics Inc
2024/01/2410:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRTXMirati Therapeutics Inc
2024/01/2410:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRTXMirati Therapeutics Inc
2024/01/2410:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRTXMirati Therapeutics Inc
2024/01/2410:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRTXMirati Therapeutics Inc
2024/01/2410:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRTXMirati Therapeutics Inc
2024/01/2410:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRTXMirati Therapeutics Inc
2024/01/2323:31Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:MRTXMirati Therapeutics Inc
2024/01/2323:31Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:MRTXMirati Therapeutics Inc
2024/01/2323:31Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:MRTXMirati Therapeutics Inc
2024/01/2323:31Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:MRTXMirati Therapeutics Inc
2024/01/2323:31Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:MRTXMirati Therapeutics Inc
2024/01/2323:31Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:MRTXMirati Therapeutics Inc
2024/01/2323:30Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:MRTXMirati Therapeutics Inc
2024/01/2323:30Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:MRTXMirati Therapeutics Inc
2024/01/2323:30Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:MRTXMirati Therapeutics Inc
2024/01/2323:30Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:MRTXMirati Therapeutics Inc
2024/01/2323:30Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:MRTXMirati Therapeutics Inc
2024/01/2323:30Edgar (US Regulatory)Form POSASR - Post-effective Amendment to an automatic shelf registration statementNASDAQ:MRTXMirati Therapeutics Inc
2024/01/2323:28Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:MRTXMirati Therapeutics Inc
2024/01/2323:27Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:MRTXMirati Therapeutics Inc
2024/01/2323:17Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:MRTXMirati Therapeutics Inc
2024/01/2322:48Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRTXMirati Therapeutics Inc
2024/01/1906:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRTXMirati Therapeutics Inc
 검색 관련기사 보기:NASDAQ:MRTX

최근 히스토리

BIT
UC27S7
Unicredit Bank
EU
Y145S
Y145S
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유